GlassScriptPhysician profile
Charlene Hester Smith
NPI 1568187961
$2,919.59
in general payments reported to CMS, 2019-2025
34 companies · $1,195 in 2025
The $1,195 reported for 2025 was more than what 87% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $808 · 2024: $917 · 2025: $1,195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,789 · Education: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,789.11 |
| Education | $130.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $693.41 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $225.12 | 2023-2025 | |
| Neurocrine Biosciences, INC. | $210.45 | 2023-2025 | Ingrezza, Ongentys |
| Acadia Pharmaceuticals INC | $206.75 | 2023-2025 | Nuplazid |
| Lundbeck LLC | $177.25 | 2023-2025 | Vyepti, Rexulti |
| Pfizer INC. | $169.40 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $128.37 | 2023-2025 | Austedo Xr |
| Tg Therapeutics, INC. | $110.30 | 2023-2025 | |
| Eisai INC. | $88.01 | 2023-2025 | |
| Ucb, INC. | $82.95 | 2023-2025 | Fintepla, Rystiggo, Briviact |
| Neurelis, INC. | $58.74 | 2023-2024 | Valtoco |
| Emd Serono, INC. | $57.98 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $57.81 | 2024 | Rexulti |
| Argenx US, INC. | $57.64 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Genentech USA, INC. | $55.73 | 2023-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $50.27 | 2025 | Hyqvia |
| Astrazeneca Pharmaceuticals LP | $49.22 | 2023-2025 | Wainua |
| Catalyst Pharmaceuticals, INC. | $49.02 | 2025 | |
| Alexion Pharmaceuticals, INC. | $44.07 | 2023 | Ultomiris |
| Lilly USA, LLC | $43.07 | 2023-2025 | Emgality, Reyvow, Kisunla |
| Genzyme Corporation | $29.61 | 2025 | |
| Amylyx Pharmaceuticals, INC. | $29.42 | 2023 | Relyvrio |
| Insightec,INC | $25.15 | 2025 | Exablate |
| Alnylam Pharmaceuticals INC. | $24.34 | 2023 | Onpattro |
| Jazz Pharmaceuticals INC. | $23.92 | 2024 | |
| Csl Behring | $22.98 | 2023 | Hizentra |
| Amneal Pharmaceuticals LLC | $22.75 | 2024 | Crexont |
| Tanabe Pharma America, INC. | $21.68 | 2025 | Radicava |
| Kyowa Kirin, INC. | $20.51 | 2024 | Nourianz |
| Mallinckrodt Hospital Products INC. | $19.29 | 2024 | Acthar |
| Hospira, INC. | $18.37 | 2023 | |
| Springworks Therapeutics, INC. | $15.52 | 2025 | Gomekli |
| Impel Pharmaceuticals INC. | $15.43 | 2023 | Trudhesa |
| Amgen INC. | $15.06 | 2024 | Uplizna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charlene Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.